Spotlighting a Next-Generation Platform to Study Cell Therapy
Time: 3:30 pm
day: Day Two
Details:
• Leveraging bioengineering, microfluidics and human ex-vivo tumors to model drug response and resistance mechanisms
• Deploying a comprehensive set of tools with ex-vivo platforms to efficiently study cell therapy including infiltration, immune response and activation of molecular pathways
